Marco Oderda - Concepedia

Author

Marco Oderda

Also Known As

M Oderda, M. Oderda, Marco MOSCHINI, Marco Moschini, Marco Oderda, Oderda Dr. Marco, Oderda M, Oderda Marco, Oderda, Marco

328

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Turin Azienda Ospedaliera Citta' della Salute e della Scienza di Torino Université Libre de Bruxelles Fondazione Ricerca Molinette Institut Jules Bordet

About

Marco Oderda is an author at University of Turin specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	1K
2	Health Sciences	5	5	202
3	Engineering	2	2	69
4	Public Health	2	2	50
5	Social Sciences	1	1	20

Marco Oderda

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients Paolo Gontero, Richard Sylvester, Francesca Pisano, European Urology Prognostic FactorsUrological ResearchUrologyBacillus Calmette-guérinUrologic Cancer Epidemiology	2014	241
The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin Paolo Gontero, Richard Sylvester, Francesca Pisano, British Journal of Urology	2015	150
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches Paolo Gontero, Giancarlo Marra, Paolo Alessio, The Journal of Urology	2019	89
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial Paolo Gontero, Marco Oderda, Anja Mehnert, The Journal of Urology	2013	78
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes Barbara Pardini, Francesca Cordero, Alessio Naccarati, Oncotarget	2018	78
External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy Romain Diamand, Guillaume Ploussard, M. Roumiguié, European Urology Urogenital RadiologyExternal ValidationUrologySurgical OncologyMedical Imaging	2020	75
A randomized double‐blind placebo controlled phase I–II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or “chemopromotion”? Paolo Gontero, Giancarlo Marra, Francesco Soria, The Prostate	2015	73
A prospective multicentric international study on the surgical outcomes and patients’ satisfaction rates of the ‘sliding’ technique for end‐stage Peyronie's disease with severe shortening of the penis and erectile dysfunction Luigi Rolle, Marco Falcone, C. Ceruti, British Journal of Urology	2015	73
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy Romain Diamand, Marco Oderda, Walid Al Hajj Obeid, World Journal of Urology UrologySurgical OncologyMedical ImagingMulticentric StudyMedicine	2019	72
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up Rossana Critelli, Francesca Fasanelli, Marco Oderda, Oncotarget Urinary Exfoliated CellsUrologyOncologyMultiple MutationsGenitourinary Cancer	2016	67

Page 1